You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
NEUWAVE™ Microwave Ablation System
NEUWAVE™ Microwave Ablation System
A comprehensive solution with proprietary features designed to allow physicians to ablate lesions of many shapes and sizes with predictability and control.1*
Features & Benefits
Address more patients with unique challenges
Provide a procedure option for unique patient challenges such as liver tumors that are difficult to resect, enable surgery for patients not typically considered for resection, ablate in addition to a resection, manage hemostasis with pre-transection coagulation (PTC), facilitate a bridge to transplants.
Help protect non-target tissue with the NEUWAVE™ PR Probe
For lesions in challenging locations where non-target tissue or structures need to be protected. The NEUWAVE PR Probe is the only probe that offers distal energy control for precise, controlled ablations with a limited distance past the tip and limited ablation length to help protect non-target tissue.
Versatile probe portfolio to control the ablation size, shape and position
Address the various needs of your patients with: NEUWAVE PR Probes with distal energy control, NEUWAVE LK probes for large single-probe ablations, minimally invasive 17 gauge probes and the ability to activate 2-3 probes simultaneously with multi-probe synchrony to reduce the risk of incomplete ablations.1
Reduce blood loss, procedure time and length of hospital stay with PTC
Utilize the dedicated surgical operating mode to create a plane of coagulation along the transection line (pre-transection coagulation or PTC) to help prepare for more hemostatic resections. Coagulation with microwave energy prior to resection has been shown to reduce blood loss, procedure time, and length of hospital stay.2
Overcome the many obstacles of radiofrequency ablation
NEUWAVE microwave ablation offers significant benefits over radiofrequency ablation including: energy readily propagates regardless of tissue type or desiccation and is less susceptible to heat sink for more predictable ablations, larger single probe ablations and multi-probe capabilities and 2-4x faster ablations.4
Utilize CO2 enabled Tissu-Loc™ Technology to help reduce probe migration
Help reduce probe migration. CO2 cooled system with Tissu-Loc™ Technology. Tissu-Loc Technology creates an ice ball at the probe tip to “stick” the probe in place. This reduces the risk of probe migration during additional scanning.
* Refer to IFU for Ablation Zone Sizes
1. Laeseke et al. Multiple-Antenna Microwave Ablation: Spatially Distributing Power Improves Thermal Profiles and Reduces Invasiveness. Journal of Interventional Oncology. 2009; 2(2):105-112. C. M. Harari, et al, Microwave Ablation: Comparison of Simultaneous and Sequential Activation of Multiple Antennas in Liver Model Systems. Radiology. 2015 Jul 2:142151.
2. Reich, D, et al. Liver Resection After Thermal Ablation of Parenchymal Transection Margin Using Microwave Energy. Clinical Liver Disease, Vol 5, No 2, February 2015
3. Millenium Interventional Oncology, Market Analysis 2016. Ethicon, Inc.
4. E. Knavel, et al. Tumor Ablation: Common Modalities and General Practices. Techniques in Vascular and Interventional Radiology 2013. NEUWAVE ex-vivo data available in probe instructions for use. D. Lu, et al. Influence of Large Peritumoral Vessels on Outcome of Radiofrequency Ablation of Liver Tumors. JVIR 2003. T. Ziemlewicz, et al. Percutaneous Microwave Ablation of Hepatocellular Carcinoma with a Gas-Cooled System: Initial Clinical Results with 107 Tumors. JVIR 2015. J.L. Hinshaw, et al. Percutaneous Tumor Ablation Tools: Microwave, Radiofrequency or Cryoablation - What Should You Use and Why? RadioGraphics 2014; 35:1344-1362.
© Ethicon US, LLC. 2019.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
This site is published by Ethicon US, LLC, which is solely responsible for its contents, and is intended for U.S. audiences only.
This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
Last updated February 20, 2019. The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.